No evidence of withdrawal syndrome was found with abrupt discontinuation of short-term treatment with 750 mg CBD twice daily (b.i.d.)for 4 weeks (Part 1) followed by 2 weeks of 750 mg b.i.d. CBD (Part 2, Arm1) or matched placebo (Part 2, Arm2). This evidence concerns the gene OPN1MW and substance withdrawal syndrome.